Physiological Role
Total vitamin B12, or cobalamin, covers all the B12 circulating in the blood. It sums two fractions: the active fraction, bound to transcobalamin and internalized by cells, and the storage fraction, bound to haptocorrin and metabolically inert. The majority of what a total B12 assay measures is the storage fraction.
Once inside the cell, active B12 drives two major enzymatic pathways. It serves as a cofactor for methionine synthase, the enzyme that converts homocysteine into methionine. This reaction fuels the methylation cycle, the biochemical process supporting DNA synthesis, neurotransmitter production, and S-adenosylmethionine, the body's principal methyl donor.
B12 also operates in the mitochondrion, assisting methylmalonyl-CoA mutase in the metabolism of specific fatty acids and amino acids. This dual localization explains why a suboptimal B12 status manifests through hematological, neurological, and energy-related signals at once.
Reference Ranges
Depending on the biomarker, Singular ranges are based on a synthesis of nutritional or clinical reference points and longevity research. They do not replace your laboratory's reference values or your healthcare professional's advice.
Biological Significance
A total vitamin B12 value in the optimal zone reflects satisfactory status across all tissues. The methylation cycle and cellular energy production have access to the cofactor they require.
Low values signal insufficient intake or absorption. At-risk profiles include vegan diets and individuals over 65. Metformin and proton pump inhibitors are also contexts to monitor. Total B12 is the universal reference measure for this status: it is measured on serum, widely available, and reimbursed in France.
When total B12 is low, homocysteine offers a complementary functional reading also measured by Singular: it rises in case of methylation impairment. The active fraction alone, Holo-TC, is more specific to tissue status, but it remains a niche assay, poorly available and not reimbursed in France. Singular therefore favors total B12, cross-referenced with homocysteine, to read functional status. In clinical settings, methylmalonic acid may complement the exploration of the mitochondrial pathway. Singular also measures vitamin B9, enabling an integrated reading of the methylation crossroads.
Very high total B12 values most often reflect a current oral intake. Other situations also raise them, notably hepatic and haematological ones. No known overload risk is attached to them, as excess B12 is eliminated through the kidneys. A high value mostly reflects recent exposure to vitamin B12 and does not prove that cellular status is satisfactory.
Influencing Factors
Diet. Vitamin B12 is synthesized by micro-organisms. In food, it is found mainly in products of animal origin (meat, fish, eggs, dairy) and in fortified foods. Strict vegan diets rapidly lead to declining B12 without adapted supplementation. Long-term vegetarian diets also carry a risk of progressive decline.
Gastrointestinal absorption. B12 absorption depends on intrinsic factor, a protein secreted by the parietal cells of the stomach. Age-related gastric atrophy reduces this secretion. This explains why B12 status weakens beyond 65, even when dietary intake is adequate.
Medications. Some medications modulate B12 absorption or availability. Metformin, used in the context of glucose metabolism, interferes with ileal absorption of vitamin B12. The DPPOS cohort documented increased risk after several years of use. Proton pump inhibitors and antacids reduce the gastric acidity needed to release B12 from food.
Genetics. Genetic variations in absorption and transport, such as polymorphisms in the FUT2 and TCN2 genes, modulate measured total B12 at equivalent intake. These variants do not alter the biological function of B12 but influence observed values.
Pregnancy. Serum vitamin B12 falls by about half during pregnancy. Dilution of blood volume and reduced synthesis of the protein that carries the storage fraction explain it. This fall does not reflect a change in vitamin B12 status.
Supplementation. Oral supplementation with methylcobalamin or cyanocobalamin rapidly raises total B12. Singular uses methylcobalamin, one of the two coenzyme forms present in human physiology. Cyanocobalamin, the most widespread synthetic form, exists in human tissues only in trace amounts.
Age. B12 needs increase with age due to reduced absorption. Regular measurement of total B12 after 50 allows intake to be adjusted before functional signals such as elevated homocysteine appear.
Methylation cofactors. Vitamins B9 and B6 participate in the same biochemical cycle as B12. An imbalanced intake can mask or amplify the reading of B12 status, justifying an integrated approach to the methylation crossroads.
In the Singular Formula
The Singular formulation engine uses total vitamin B12 as a marker of B12 status. Several concrete rules adjust the formula based on the observed zone.
When total B12 sits in the low zone, vitamin B12 is calibrated to an intermediate dosage to restore cellular availability. In the very low zone, the dose is reinforced further. Singular formulates with methylcobalamin, one of the two coenzyme forms of vitamin B12 in human physiology. When the marker reaches the first third of the optimal zone, the formula moves to a maintenance dose. Beyond that, no rule adds vitamin B12 on B12 status alone.
A specific safety logic frames vitamin B9. High folate intake can mask the hematological picture without changing actual B12 availability, blurring the reading of B12 status. When total B12 is low, vitamin B9 dosing is capped to avoid masking B12 dynamics.
The engine systematically cross-references total B12 with two other markers of the methylation crossroads. When homocysteine is elevated and total B12 remains low, vitamin B12 takes priority. When homocysteine is elevated and total B12 is already optimal, the formula adds vitamin B12 at its maintenance dose. This addition assumes that vitamin B9 is also optimal, and that alkaline phosphatase is not very high. A folate reinforcement, by contrast, requires a low vitamin B9. The transsulfuration pathway, supported by P5P, is the other homocysteine recycling route. This cross-reading avoids generic corrections and targets the truly limiting link.
Beyond B12 itself, vitamin B6 in its P5P form is selected for its documented contribution to the methylation cycle. Iron, whose metabolism intersects with red blood cell formation, completes this integrated reading of hematological and energy status.
Linked Bioactives
Scientific Studies
| Authors | Year | Type | Journal | |
|---|---|---|---|---|
| Hooshmand B, Solomon A, Kåreholt I, et al. | 2010 | Cohort Study | Neurology | View on PubMed |
Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study CAIDE cohort of 271 elderly Finnish subjects followed for 7 years. The exposure measured is holotranscobalamin, the active fraction of vitamin B12, not total B12: each additional picomole per litre was associated with less frequent onset of Alzheimer disease over the period. Homocysteine is analysed as a separate exposure. | ||||
| Aroda VR, Edelstein SL, Goldberg RB, et al. | 2016 | Cohort Study | Journal of Clinical Endocrinology & Metabolism | View on PubMed |
Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study Thirteen-year follow-up of the DPPOS cohort. On metformin, low or borderline-low B12 status (≤ 298 pg/mL) affected 19.1% of participants at 5 years and 20.3% at 13 years, against 9.5% and 15.6% on placebo. Low status alone affected 4.3% and 7.4%. Risk rose by 13% per year of use. | ||||
| Smith AD, Smith SM, de Jager CA, et al. | 2010 | Randomised Controlled Trial | PLoS One | View on PubMed |
Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial VITACOG randomized controlled trial in subjects over 70; 168 participants completed the brain imaging arm. Supplementation combining folate, vitamin B12 and vitamin B6 slowed brain atrophy by 30% on average, and by 53% in subjects whose homocysteine exceeded 13 µmol/L. | ||||
| Choudhury A, Jena A, Jearth V, et al. | 2023 | Meta-analysis | Expert Review of Gastroenterology & Hepatology | View on PubMed |
Vitamin B12 deficiency and use of proton pump inhibitors: a systematic review and meta-analysis Meta-analysis of 25 studies comparing 2,852 proton pump inhibitor users with 28,070 non-users. The pooled odds ratio for low B12 status was 1.42, but the authors judge it too low and the heterogeneity too high to state the association clearly. Most included studies found no difference in serum B12 between the two groups. | ||||
| Jarquin Campos A, Risch L, Nydegger U, et al. | 2020 | Observational Study | Disease Markers | View on PubMed |
Diagnostic Accuracy of Holotranscobalamin, Vitamin B12, Methylmalonic Acid, and Homocysteine in Detecting B12 Deficiency in a Large, Mixed Patient Population 11,833 samples, four markers compared in the same population. The areas under the curve are close: 0.92 for holotranscobalamin, 0.91 for methylmalonic acid, 0.90 for total B12 and 0.78 for homocysteine. In men and in women under 50, no marker outperformed total B12. | ||||
| Harrington DJ, Stevenson E, Sobczyńska-Malefora A | 2025 | Review | Annals of Clinical Biochemistry | View on PubMed |
The application and interpretation of laboratory biomarkers for the evaluation of vitamin B12 status Open-access review on the interpretation of vitamin B12 markers. It places the usual decision point for low status around 148 pmol/L, describes the indeterminate range of 133 to 258 pmol/L retained by British guidelines, and notes that the majority of what a total B12 assay measures is the storage fraction. It also documents the fall of about 50% during pregnancy. | ||||